We are live on ! Find out more
PMD

Psychemedics Corporation

Delisted

PMD was delisted on the 12th of December, 2024.

52 hedge funds and large institutions have $72.1M invested in Psychemedics Corporation in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

18% more capital invested

Capital invested by funds: $61M → $72.1M (+$11.1M)

18% more funds holding

Funds holding: 4452 (+8)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
52
Holders Change
+8
Holders Change %
+18.18%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
16
Reduced
15
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$4K -$22.4K -1,000 -85%
MA
52
MUFG Americas
New York
$3K +$3.16K +141 New
KCM
53
Kennedy Capital Management
Missouri
-$1.47M -74,226 Closed
TRCT
54
Tower Research Capital (TRC)
New York
-$46K -2,299 Closed

PMD Hedge Fund Activity: Q4 2016 in Review

52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2016, worth a combined $72.1M — up 18% from $61M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new PMD positions and 2 closed out — a net gain of 8 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.46M. The largest seller was Uniplan Investment Counsel, cutting an estimated $4.61M.

  • 52 institutional investors held Psychemedics Corporation (PMD) as of Q4 2016, up from 44 in Q3 2016.
  • Funds reported $72.1M of Psychemedics Corporation stock for Q4 2016, up 18% quarter-over-quarter.
  • 10 funds opened new Psychemedics Corporation positions in Q4 2016 and 2 closed out, a net change of +8 holders.
  • The largest Psychemedics Corporation buyer in Q4 2016 was Renaissance Technologies, an estimated $1.46M added.
  • The largest Psychemedics Corporation seller in Q4 2016 was Uniplan Investment Counsel, an estimated $4.61M sold.

Based on aggregated 13F filings for Q4 2016.